These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


457 related items for PubMed ID: 7958670

  • 1. Cholecystokinin is a negative regulator of gastric acid secretion and postprandial release of gastrin in humans.
    Schmidt WE, Schenk S, Nustede R, Holst JJ, Fölsch UR, Creutzfeldt W.
    Gastroenterology; 1994 Dec; 107(6):1610-20. PubMed ID: 7958670
    [Abstract] [Full Text] [Related]

  • 2. Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori.
    Konturek JW.
    J Physiol Pharmacol; 1994 Dec; 45(4 Suppl 1):3-66. PubMed ID: 7787215
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cholecystokinin is a physiological regulator of gastric acid secretion in man.
    Burckhardt B, Delco F, Ensinck JW, Meier R, Bauerfeind P, Aufderhaar U, Ketterer S, Gyr K, Beglinger C.
    Eur J Clin Invest; 1994 Jun; 24(6):370-6. PubMed ID: 7957488
    [Abstract] [Full Text] [Related]

  • 6. Cholecystokinin in the control of gastric acid secretion in humans.
    Konturek JW, Gutwinska-Konturek M, Gabryelewicz A, Konturek SJ, Domschke W.
    J Clin Gastroenterol; 1993 Jun; 17 Suppl 1():S40-5. PubMed ID: 7904286
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Role of cholecystokinin in the control of gastric emptying and secretory response to a fatty meal in normal subjects and duodenal ulcer patients.
    Konturek JW, Thor P, Maczka M, Stoll R, Domschke W, Konturek SJ.
    Scand J Gastroenterol; 1994 Jul; 29(7):583-90. PubMed ID: 7939393
    [Abstract] [Full Text] [Related]

  • 9. Eradication of Helicobacter pylori and gastrin-somatostatin link in duodenal ulcer patients.
    Konturek JW, Bielański W, Konturek SJ, Domschke W.
    J Physiol Pharmacol; 1996 Mar; 47(1):161-75. PubMed ID: 8777296
    [Abstract] [Full Text] [Related]

  • 10. Cholecystokinin in the control of gastric acid secretion in man.
    Konturek JW, Stoll R, Konturek SJ, Domschke W.
    Gut; 1993 Mar; 34(3):321-8. PubMed ID: 8472978
    [Abstract] [Full Text] [Related]

  • 11. Loxiglumide inhibits cholecystokinin stimulated somatostatin secretion and simultaneously enhances gastric acid secretion in humans.
    Verhulst ML, Gielkens HA, Hopman WP, van Schaik A, Tangerman A, Rovati LC, Jansen JB.
    Regul Pept; 1994 Oct 21; 53(3):185-93. PubMed ID: 7846294
    [Abstract] [Full Text] [Related]

  • 12. Physiological role of cholecystokinin on gastric emptying and acid output in dogs.
    Jin HO, Lee KY, Chang TM, Chey WY, Dubois A.
    Dig Dis Sci; 1994 Nov 21; 39(11):2306-14. PubMed ID: 7956596
    [Abstract] [Full Text] [Related]

  • 13. Cholecystokinin in the regulation of gastric acid and endocrine pancreatic secretion in humans.
    Konturek JW, Stoll R, Gutwinska-Konturek M, Konturek SJ, Domschke W.
    Scand J Gastroenterol; 1993 May 21; 28(5):401-7. PubMed ID: 8511500
    [Abstract] [Full Text] [Related]

  • 14. Effect of loxiglumide on basal and gastrin- and bombesin-stimulated gastric acid and serum gastrin levels.
    Jebbink MC, Lamers CB, Mooy DM, Rovati LC, Jansen JB.
    Gastroenterology; 1992 Oct 21; 103(4):1215-20. PubMed ID: 1397878
    [Abstract] [Full Text] [Related]

  • 15. Role of cholecystokinin in the inhibition of gastric acid secretion in dogs.
    Konturek SJ, Bilski J, Tasler J, Cieszkowski M.
    J Physiol; 1992 Oct 21; 451():477-89. PubMed ID: 1403819
    [Abstract] [Full Text] [Related]

  • 16. A physiological role for cholecystokinin as a regulator of gastrin secretion.
    Beglinger C, Hildebrand P, Meier R, Bauerfeind P, Hasslocher H, Urscheler N, Delco F, Eberle A, Gyr K.
    Gastroenterology; 1992 Aug 21; 103(2):490-5. PubMed ID: 1634067
    [Abstract] [Full Text] [Related]

  • 17. Eradication of Helicobacter pylori restores the inhibitory effect of cholecystokinin on postprandial gastrin release in duodenal ulcer patients.
    Konturek JW, Gillessen A, Konturek SJ, Domschke W.
    Gut; 1995 Oct 21; 37(4):482-7. PubMed ID: 7489932
    [Abstract] [Full Text] [Related]

  • 18. Involvement of endogenous cholecystokinin and somatostatin in gastroprotection induced by intraduodenal fat.
    Brzozowski T, Konturek PC, Konturek SJ, Kwiecién S, Pajdo R, Brzozowska I, Hahn EG.
    J Clin Gastroenterol; 1998 Oct 21; 27 Suppl 1():S125-37. PubMed ID: 9872509
    [Abstract] [Full Text] [Related]

  • 19. Comparison of loxiglumide, a cholecystokinin receptor antagonist, and atropine on hormonal and meal-stimulated pancreatic secretion in man.
    Gabryelewicz A, Kulesza E, Konturek SJ.
    Scand J Gastroenterol; 1990 Jul 21; 25(7):731-8. PubMed ID: 2396088
    [Abstract] [Full Text] [Related]

  • 20. Increased gastric acid secretion in cholecystokinin-1 receptor-deficient Otsuka Long-Evans Tokushima fatty rats.
    Kanagawa K, Nakamura H, Murata I, Yosikawa I, Otsuki M.
    Scand J Gastroenterol; 2002 Jan 21; 37(1):9-16. PubMed ID: 11843043
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 23.